The Evolution of STI Testing: A Catalyst for Modern Diagnostic Technologies
solutions that prioritize convenience and patient autonomy. In response, diagnostic companies and healthcare providers are reimagining the testing experience through patient-centered design— focusing on accessibility, confidentiality and ease of use. Decentralization continues to expand patient opportunities, with testing now available not only in laboratories but also in pharmacies, community centers and homes. Digital connectivity enhances this ecosystem by linking results to electronic health records, telemedicine services and public health surveillance systems, creating a more seamless continuum of care. References 1. Swain, G. R., et al. (2004). Decision analysis: Point-of-care chla- mydia testing vs. laboratory-based methods. Clinical Medicine & Research, 2 (1), 29-35. https://doi.org/10.3121/cmr.2.1.29 2. Caruso, G., et al. (2021). Current and future trends in the labora- tory diagnosis of sexually transmitted infections. International Journal of Environmental Research and Public Health, 18 (3), 1038. https://doi.org/10.3390/ijerph18031038 3. Karellis, A., et al. (2022). Multiplexed rapid technologies for sexually transmitted infections: A systematic review. The Lancet Microbe, 3 (4), e303-e315. https://doi.org/10.1016/ S2666-5247(21)00191-9 4. Mordor Intelligence. (2025, November 10). STD diag- nostics market size & share analysis—Growth trends and forecast (2025-2030) . Retrieved from https:// www.mordorintelligence.com/industry-reports/ sexually-transmitted-diseases-std-diagnostics-market 5. Grand View Research. (n.d.). Molecular diagnostics for sexually transmitted diseases (STD) market—Industry report 2033 . Retrieved from https://www.grandviewresearch.com/ industry-analysis/molecular-diagnostics-std-market-report 6. Huppert, J., et al. (2010). What is the point? How point-of-care sexually transmitted infection tests can impact infected patients. Point of Care: The Journal of Near-Patient Testing & Technology, 9 (1), 36-46. https://doi.org/10.1097/POC.0b013e3181d2d8cc
Rather than replacing traditional services, at-home and self-collection kits are proving complementary. Research shows that direct- to-consumer testing attracts individuals who might otherwise avoid clinical settings, while others use both self-testing and clinic-based care at different points in their sexual health routines. 11 These innovations also carry broader implications. Advances in self-collection, digital integration and multiplexed POC platforms are increasingly transferable to other infectious disease areas. In this way, progress in STI diagnostics is not only improving sexual health but also shaping the future of diagnostics more broadly. 7. Shaw, J. L. V. (2016). Practical challenges related to point-of-care testing. Practical Laboratory Medicine, 4 , 22-29. https://doi. org/10.1016/j.plabm.2015.12.002 8. Kersh, E. N., et al. (2021). At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: A review of laboratory implementation issues. Journal of Clinical Microbiology, 59 (11), e02646-20. https://doi.org/10.1128/JCM.02646-20 9. McGuire, M., et al. (2021). HIV self-testing with digital supports as the new paradigm: A systematic review of global evidence (2010-2021). EClinicalMedicine, 39 , 101059. https://doi. org/10.1016/j.eclinm.2021.101059 10. MacKinnon, K. R., et al. (2021). Pay to skip the line: The political economy of digital testing services for HIV and other sexually transmitted infections. Social Science & Medicine, 268 , 113571. https://doi.org/10.1016/j.socscimed.2020.113571 11. Martín-García, D. F., & Santi-Rocca, J. (2024). Direct-to-Consumer Testing: A Game-Changer for STI Control and Public Health? A Critical Review of Advances Since the Onset of the COVID-19 Pandemic. Venereology, 3 (4), 232-245. https://doi.org/10.3390/ venereology3040018
GENengnews.com | 11
Powered by FlippingBook